The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats

Molecular Biology Reports

Volumn 39, Issue 9, 2012, Pages 9085-9093

  Wu, Lina ^a   Zhang, Yinghui ^a   Ma, Xiaokun ^a   Zhang, Na ^a   Qin, Guijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Forkhead transcription factor O1; Oxidative stress; Resveratrol; Silent information regulator 1

Indexed keywords

CATALASE; COLLAGEN TYPE 4; FIBRONECTIN; MALONALDEHYDE; RESVERATROL; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR FKHR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE MARKER; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; KIDNEY; KIDNEY CORTEX; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CATALASE; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; FIBRONECTINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; KIDNEY; MALE; NERVE TISSUE PROTEINS; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIRTUIN 1; STILBENES;

RATTUS;

EID: 84865145752     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1780-z     Document Type: Article

References (27)

1. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446-1454
2. Ha H, Hwang IA, Park JH, Lee HB (2008) Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res Clin Pr 82:S42-S45
3. Wagener FA, Dekker D, Berden JH, Scharstuhl A, van der Vlag J (2009) The role of reactive oxygen species in apoptosis of the diabetic kidney. Apoptosis 14:1451-1458
4. Ha H, Lee HB (2000) Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 58:S19-S25
5. Xia L, Wang H, Goldberg HJ, Munk S, Fantus IG et al (2006) Mesangial cell NADPH oxidase upregulation in high glucose is PKC dependent and required for collagen IV expression. Am J Physiol Renal Physiol 290:F345-F356 (Pubitemid 43724989)
6. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B et al (2005) NOX4 NADPH oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616-39626 (Pubitemid 41713921)
7. Rösen P, Nawroth PP, King G, Möller W, Tritschler HJ et al (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabete society. Diab Metab Res Rev 17:189-212 (Pubitemid 32624602)
8. Melhem MF, Craven PA, Derubertis FR (2001) Effects of dietary supplementation of α-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12:124-133 (Pubitemid 32056797)
9. Schnackenberg CG, Wilcox CS (2001) The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59:1859-1864 (Pubitemid 32336801)
10. Daitoku H, Fukamizu A (2007) FOXO transcription factors in the regulatory networks of longevity. Jpn Biochem Soc 141:769-774 (Pubitemid 351455333)
11. Sedding DG (2008) FoxO transcription factors in oxidative stress response and ageing-a new fork on the way to longevity? Bio Chem 389:279-283 (Pubitemid 351329031)
12. Venkatesan B, Mahimainathan L, Das F, Ghosh-Choudhury N, Ghosh Choudhury G (2007) Downregulation of catalase by reactive oxygen species via PI3 Kinase/Akt signaling in mesangial cells. J Cell Physiol 211:457-467 (Pubitemid 46580099)
13. Kato M, Yuan H, Xu ZG, Lanting L, Li SL et al (2006) Role of the Akt/FoxO3a pathway in TGF-β1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17:3325-3335 (Pubitemid 44865275)
14. Zhang J (2006) Resveratrol inhibits insulin responses in a SirT1-independent pathway. Biochem J 397:519-527 (Pubitemid 44032841)
15. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
16. Kitada M, Kume S, Imaizumi N, Koya D (2011) Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60:634-643
17. Subauste AR, Burant CF (2007) Role of FoxO1 in FFA-induced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab 293:E159-E164 (Pubitemid 47105929)
18. Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol induces growth arrest and Apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5:e15288
19. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196 (Pubitemid 37150899)
20. Park JM, Kim TH, Bae JS, Kim MY, Kim KS et al (2010) Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver. Biochem Biophys Res Commun 403:329-334
21. Xu ZG, Li SL, Lanting L, Kim YS, Shanmugam N et al (2006) Relationship between 12/15-lipoxygenase and COX-2 in mesangial cells: potential role in diabetic nephropathy. Kidney Int 69:512-519 (Pubitemid 43164443)
22. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015 (Pubitemid 38393275)
23. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H et al (2005) NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 288:F1144-F1152 (Pubitemid 40677084)
24. Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T et al (2004) Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 101:10042-10047 (Pubitemid 38891191)
25. Giannakou ME, Partridge L (2004) The interaction between FOXO and SIRT1: tipping the balance towards survival. Trends Cell Biol 14:408-412 (Pubitemid 39092697)
26. Guarente L (2007) Srtuins in aging and disease. Cold Spring Harb Symp Quant Biol 72:483-488
27. Frescas D, Valenti L, Accili D (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem 280:20589-20595 (Pubitemid 40776761)